Korro Bio, Inc.(KRRO)

Biotechnology · Cambridge, MA

$9.71-0.26 (-2.61%)

Delayed quote: Oct 6, 2026, 2:05 PM EDT

Korro Bio (KRRO) EBITDA Yield: History & Chart | TGMCharts

EBITDA Yield: N/A

Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The EBITDA yield is N/A as of 2026-10-06T18:08:17.277Z.

Stored calculation inputs

Calculation as of: 2026-10-06T18:08:17.277Z.

Quote observation: 2026-10-06T18:05:12.000Z. Amounts in USD. The price header may show a later quote.

TTM operating EBITDA · period ending 2026-06-30: -73,093,000
Quote market capitalization: 96,647,194
Total debt · period ending 2026-06-30: 42,213,000
Cash · period ending 2026-06-30: 24,905,000

FMP input reference: eea6c7d5cd6e3fe508f4e89a8ac0afa25f3437e05bd10ab9ad2dfceb562d4ef8

EV/EBITDA|Earnings Yield|OCF Yield|FCF Yield|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

KRRO EBITDA Yield Metrics

EBITDA YIELD

N/A

KRRO Competitors' EBITDA Yield

KRRO

Korro Bio, Inc.

Current

Market Cap

$96.65M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MIST

Milestone Pharmaceuticals Inc.

vs KRRO

Market Cap

$97.28M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CNXU

Conexeu Sciences Inc.

vs KRRO

Market Cap

$99.01M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PYPD

PolyPid Ltd.

vs KRRO

Market Cap

$99.23M

EBITDA Yield

N/A

TTM Avg

1.73%

3Y Avg

1.73%

5Y Avg

132.35%

PARK

Park Dental Partners, Inc. Common Stock

vs KRRO

Market Cap

$92.33M

EBITDA Yield

N/A

TTM Avg

2.46%

3Y Avg

2.46%

5Y Avg

2.46%

BMEA

Biomea Fusion, Inc.

vs KRRO

Market Cap

$91.46M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

RLYB

Rallybio Corporation

vs KRRO

Market Cap

$90.32M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

JYNT

The Joint Corp.

vs KRRO

Market Cap

$102.64M

EBITDA Yield

3.83%

TTM Avg

2.60%

3Y Avg

2.68%

5Y Avg

2.72%

Equillium, Inc.

vs KRRO

Market Cap

$90.41M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

OKUR

OnKure Therapeutics, Inc.

vs KRRO

Market Cap

$103.06M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EBITDA YIELD	TTM	3Y	5Y
Korro Bio, Inc. (KRRO)	$96.65M	N/A	N/A	N/A	N/A
Milestone Pharmaceuticals Inc. (MIST)vs ›	$97.28M	N/A	N/A	N/A	N/A
Conexeu Sciences Inc. (CNXU)vs ›	$99.01M	N/A	N/A	N/A	N/A
PolyPid Ltd. (PYPD)vs ›	$99.23M	N/A	1.73%	1.73%	132.35%
Park Dental Partners, Inc. Common Stock (PARK)vs ›	$92.33M	N/A	2.46%	2.46%	2.46%
Biomea Fusion, Inc. (BMEA)vs ›	$91.46M	N/A	N/A	N/A	N/A
Rallybio Corporation (RLYB)vs ›	$90.32M	N/A	N/A	N/A	N/A
The Joint Corp. (JYNT)vs ›	$102.64M	3.83%	2.60%	2.68%	2.72%
Equillium, Inc. (EQ)vs ›	$90.41M	N/A	N/A	N/A	N/A
OnKure Therapeutics, Inc. (OKUR)vs ›	$103.06M	N/A	N/A	N/A	N/A

EBITDA Yield Formula & Definition

EBITDA Yield = TTM EBITDA / Enterprise Value

EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EBITDA Yield: N/A

KRRO EBITDA Yield Metrics

KRRO Competitors' EBITDA Yield

EBITDA Yield Formula & Definition

Related Metrics